Covid19

Covid-19: Has the spread of omicron BA.2 made antibody treatments redundant? | The BMJ

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) authorised sotrovimab for high risk over 12s with mild to moderate covid-19 in …

Read more at www.bmj.com

Show More

Related Articles

Back to top button